Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Technology Update

5 Jun 2007 15:00

ViaLogy PLC05 June 2007 ViaLogy Announces IPv6-capable MicroSPM(TM)for High Definition SurveillanceVideo Processing LONDON, June 5, 2007 -- ViaLogy plc (LSE: VIY), announced today that it hasdeveloped IPv6-capable MicroSPM(TM), compact embedded hardware for highdefinition video processing applications over IP-converged networks. MicroSPM(TM)extends ViaLogy's SPM(TM)software product family by delivering anetwork-centric hardware policy-engine for fully-autonomous incident-based rapiddetection, analysis and response. The MicroSPM(TM)platform addresses threemajor trends within the global surveillance industry: increasing adoption ofnetwork addressable digital video camera and thermal imagers; need for real-timeautonomous processing by moving the policy and the intelligence to the networkedge, and, the accelerated migration to IPv6 addressing standards. MicroSPM(TM)is powered by ViaLogy's proprietary, patented signal processingQuantum Resonance Interferometry ("QRI") technology for detecting weak signalsand image features in high background clutter. QRI delivers video-applicationsin the form of prepackaged user customizable policies in firmware. Initialapplications include: face-extraction in crowds; human, object and vehicledetection and counting, and license plate reading. Immediate verticals includedefense, oil & gas, enterprise safety and security, and, perimeter and bordersurveillance. MicroSPM(TM)enables high speed processing at the video source,only transmitting policy-based exceptions and events to the operator sites. Italso delivers plug-and-play interoperability for IP-enabled video and night-vision devices from different vendors. Today, video surveillance systems are an essential remote monitoring tool forcritical infrastructure, including airports, border crossings, ports, dams,trains and subways; financial and governmental institutions; power grids,utilities and refining facilities. Video is routinely used by businesses formonitoring entrances, walkways, parking lots and warehouses. In banks andretail, surveillance cameras are strategically positioned to monitor and recordthe behavior of customers and tellers. However, the bulk of decision making isperformed by human operators staring at multiple video consoles and manuallycontrolling cameras. Size of this overall video surveillance market is estimatedat over $3 billion for 2007, with sales of security cameras exceeding 6 millionunits and growing at over 30%. According to ViaLogy CTO, Dr. Sandeep Gulati, "Centralized operator-based videoviewing and security decision making is a major choke-point in timely response.Bulk of video is archived and only used for post-incident analysis. MicroSPM'real-time edge processing will significantly expand the actionable informationbandwidth for customers. This is consistent with our focus on broad marketapplications where ViaLogy's QRI signal processing becomes an enabler." ViaLogy President and CEO, Mr. Shah Talukder stated "Customers are facingsignificant challenges in managing a multitude of sensor, video and otherdevices in their networked environments. We see a significant opportunity forscaleable, cost effective and future-proof solutions to manage their global andregional security networks." He added, "We also see MicroSPM(TM)enablingpartners to IPv6-enable their fixed and mobile sensors and network subsystems". Vialogy is in discussions with customers and partners to pilot and deployMicroSPM(TM)within their surveillance infrastructure. For further information please contact: ViaLogyShah Talukder, President & CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSAcquisition of French distribution channel
17th Feb 20207:00 amRNSCE Marking Technical File submission
14th Feb 202011:00 amRNSMedilink Award win for Outstanding Achievement
14th Feb 20207:00 amRNSTGA approves DPYD for sale in Australia
5th Dec 201912:10 pmRNSThe Healthcare+ Expo Taiwan
2nd Dec 20197:00 amRNSHalf-year Report
29th Nov 201912:05 pmRNSBionow Double Award Win
28th Nov 20197:00 amRNSOpening of New Facilities and Corporate HQ
15th Nov 20197:00 amRNSPrivate Investor Presentation
12th Nov 201910:12 amRNSNotice of Results
6th Nov 20191:52 pmRNSCapital Markets Day
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSLaunch of Yourgene FlexT Analysis Software
30th Oct 20197:00 amRNSIssue of Share Options
15th Oct 20197:00 amRNSAmerican Society of Human Genetics Annual Meeting
14th Oct 20197:00 amRNSHalf year trading update
1st Oct 20197:00 amRNSPrivate Investor Presentation
26th Sep 20197:00 amRNSCE-IVD Certification renewal
18th Sep 20197:00 amRNSLaunch of DPYD chemotoxicity diagnostic assay
17th Sep 20195:50 pmRNSResult of AGM
17th Sep 20197:00 amRNSAGM Statement
20th Aug 20197:00 amRNSNotice of AGM
19th Aug 201910:35 amRNSChange of Registered Office
16th Aug 20193:49 pmRNSHolding(s) in Company
16th Aug 20199:06 amRNSDirectorate Change
12th Aug 20197:00 amRNSAmendment to Share Options
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:00 amRNSAppointment of Director
10th Jul 20197:00 amRNSFinal Results, Business Update and Director Change
27th Jun 20197:00 amRNSNotice of Results
24th Jun 20197:00 amRNSYourgene participates in key global conferences
3rd Jun 20197:01 amRNSDirector's dealing
3rd Jun 20197:00 amRNSIssue of Share Options
9th May 20194:07 pmRNSDirector's dealing
9th May 20197:00 amRNSDirectors' dealing & warrant extension
1st May 20198:05 amRNSTotal Voting Rights
26th Apr 20195:12 pmRNSHolding(s) in Company
26th Apr 20195:01 pmRNSHolding(s) in Company
25th Apr 20194:40 pmRNSCompletion of Acquisition
18th Apr 20197:00 amRNSResults of Placing and Subscription
17th Apr 20194:50 pmRNSAppointment of Sole Corporate Broker
17th Apr 20194:48 pmRNSProposed Acquisition, Placing & Subscription
8th Apr 20197:00 amRNSFull-year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.